期刊
JOURNAL OF BIOLOGICAL CHEMISTRY
卷 286, 期 23, 页码 20710-20726出版社
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M110.213538
关键词
-
资金
- National Institutes of Health [GM089853]
- NINDS [2R01NS39074, 1KO8NS062954-01A1, NS057096]
- NIA [P01AG022074, AG18440, AG022074]
- NIDA [DA10154]
- Hillblom Foundation
- Alzheimer's Disease Research Center
- Burroughs-Wellcome Medical Scientist Fund Carrer Award
- University of California San Francisco
- Taube-Koret Center
- McKnight Foundation
The protein alpha-synuclein has a central role in Parkinson disease, but the mechanism by which it contributes to neural degeneration remains unknown. We now show that the expression of alpha-synuclein in mammalian cells, including neurons in vitro and in vivo, causes the fragmentation of mitochondria. The effect is specific for synuclein, with more fragmentation by alpha- than beta- or gamma-isoforms, and it is not accompanied by changes in the morphology of other organelles or in mitochondrial membrane potential. However, mitochondrial fragmentation is eventually followed by a decline in respiration and neuronal death. The fragmentation does not require the mitochondrial fission protein Drp1 and involves a direct interaction of synuclein with mitochondrial membranes. In vitro, synuclein fragments artificial membranes containing the mitochondrial lipid cardiolipin, and this effect is specific for the small oligomeric forms of synuclein. alpha-Synuclein thus exerts a primary and direct effect on the morphology of an organelle long implicated in the pathogenesis of Parkinson disease.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据